10-99806422-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000392.5(ABCC2):c.1531-962A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.955 in 152,244 control chromosomes in the GnomAD database, including 69,446 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.95 ( 69446 hom., cov: 30)
Consequence
ABCC2
NM_000392.5 intron
NM_000392.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.210
Publications
3 publications found
Genes affected
ABCC2 (HGNC:53): (ATP binding cassette subfamily C member 2) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008]
ABCC2 Gene-Disease associations (from GenCC):
- Dubin-Johnson syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.955 AC: 145273AN: 152126Hom.: 69387 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
145273
AN:
152126
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.955 AC: 145391AN: 152244Hom.: 69446 Cov.: 30 AF XY: 0.958 AC XY: 71268AN XY: 74422 show subpopulations
GnomAD4 genome
AF:
AC:
145391
AN:
152244
Hom.:
Cov.:
30
AF XY:
AC XY:
71268
AN XY:
74422
show subpopulations
African (AFR)
AF:
AC:
39592
AN:
41532
American (AMR)
AF:
AC:
14488
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
3108
AN:
3472
East Asian (EAS)
AF:
AC:
5172
AN:
5174
South Asian (SAS)
AF:
AC:
4772
AN:
4826
European-Finnish (FIN)
AF:
AC:
10475
AN:
10608
Middle Eastern (MID)
AF:
AC:
243
AN:
292
European-Non Finnish (NFE)
AF:
AC:
64685
AN:
68032
Other (OTH)
AF:
AC:
1969
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
322
644
967
1289
1611
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3440
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.